Intracerebral CD19-specific CAR T cell injection to mice with CNS lymphoma was found to result in the migration of CAR T cells to the ‘healthy’ contralateral brain hemisphere, albeit at lower numbers (Mulazzani et al., 2019). The gene discussed is CD19; the disease is primary central nervous system lymphoma.